Literature DB >> 19952999

Surgical treatment of severely traumatized eyes with no light perception.

Ebadollah Heidari1, Nazli Taheri.   

Abstract

PURPOSE: The purpose of this study was to evaluate the anatomical and functional outcomes of surgical intervention in severely traumatized eyes with no light perception (NLP).
METHODS: In this prospective interventional case series, 18 eyes of 18 patients with severe ocular trauma whose vision was documented as NLP and with relative afferent pupillary defect of 3 to 4+ underwent deep vitrectomy and other appropriate procedures 1 to 3 times.
RESULTS: Vision was NLP in all eyes at the time of surgery, which was performed 3 days to 14 days after the initial trauma. During a mean follow-up period of 20.5 +/- 5.2 months (range, 11-36 months), except for 1 case of phthisis, other eyes achieved acceptable anatomical and functional outcomes. Postoperative vision was NLP in 2 eyes (11.1%), light perception in 3 eyes (16.7%), hand motions in 4 eyes (22.2%), counting fingers in 3 eyes (16.7%), and 20/200 or better in 6 eyes (33.4%).
CONCLUSION: After eye trauma, NLP vision and relative afferent pupillary defect of 3 to 4+ alone may not be an indication for enucleation. Performing exploratory surgery within 14 days after the injury may salvage the globe and improve vision; this approach also entails positive psychologic effects for patients and relatives.

Entities:  

Mesh:

Year:  2010        PMID: 19952999     DOI: 10.1097/IAE.0b013e3181babd75

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  15 in total

1.  Vitreoretinal surgery in the management of war-related open-globe injuries.

Authors:  Ernest V Boiko; Sergey V Churashov; Natalya N Haritonova; Anatoly A Budko
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-09       Impact factor: 3.117

2.  A 10-year review of assault-related open-globe injuries at an urban hospital.

Authors:  Alain M Bauza; Parisa Emami; Nishant Soni; Bart K Holland; Paul Langer; Marco Zarbin; Neelakshi Bhagat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-22       Impact factor: 3.117

Review 3.  Mild-to-Moderate Traumatic Brain Injury: A Review with Focus on the Visual System.

Authors:  Steven H Rauchman; Jacqueline Albert; Aaron Pinkhasov; Allison B Reiss
Journal:  Neurol Int       Date:  2022-05-30

4.  Enucleation in pediatric open globe injuries: demographics and risk factors.

Authors:  Siri Uppuluri; Aditya Uppuluri; Paul D Langer; Marco A Zarbin; Neelakshi Bhagat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-16       Impact factor: 3.535

5.  SILICONE OIL-FILLED FOLDABLE CAPSULAR VITREOUS BODY VERSUS SILICONE OIL ENDOTAMPONADE FOR TREATMENT OF NO LIGHT PERCEPTION AFTER SEVERE OCULAR TRAUMA.

Authors:  Chun Zhang; Ruihan Xiao; Anan Wang; Zhenquan Zhao
Journal:  Retina       Date:  2022-03-01       Impact factor: 3.975

6.  Vitrectomy combined with silicone oil tamponade in the treatment of severely traumatized eyes with the visual acuity of no light perception.

Authors:  Shan-Shan Yang; Tao Jiang
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

7.  Predictive factors for final outcome of severely traumatized eyes with no light perception.

Authors:  Rupesh Agrawal; Ho Sue Wei; Stephen Teoh
Journal:  BMC Ophthalmol       Date:  2012-06-19       Impact factor: 2.209

8.  Prognostic factors for final vision outcome in patients with open globe injuries.

Authors:  Rupesh Agrawal
Journal:  Indian J Ophthalmol       Date:  2011 May-Jun       Impact factor: 1.848

9.  Visual recovery following open globe injury with initial no light perception.

Authors:  Yong S Han; Shaheen C Kavoussi; Ron A Adelman
Journal:  Clin Ophthalmol       Date:  2015-08-11

10.  Complete Visual Rehabilitation in a Patient with No Light Perception after Surgical Management of a Penetrating Open-Globe Injury: A Case Report.

Authors:  Tania A Baban; Fady K Sammouh; Haytham M ElBallouz; Elias L Warrak
Journal:  Case Rep Ophthalmol       Date:  2015-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.